DCC Healthcare is an independently run division of DCC plc and delivers future-focused solutions across energy, healthcare and technology sectors. The acquisition of DCC Healthcare allows Investindustrial to leverage its strong track record and expertise in the food supplement CDMO and medical devices verticals. The acquisition values DCC Healthcare at a total enterprise value of £1,050 billion on a cash-free, debt-free basis. The transaction was announced on 22 April 2025 and is expected to complete in Q3 2025.

The team was led by Christopher McLaughlin (Corporate and M&A), Colin Kavanagh (Regulatory), Sarah McCague (Pensions and Employee Benefits), Kevin Langford (Employment) and Orlaith Kane (Tax), and included Tim Gleeson and Éimear Devaney (Corporate and M&A), Robert Byrne (Regulatory), Ross Neill (Pensions and Employee Benefits), Declan MacQuillan (Employment) and Ruth O’Sullivan (Tax).

We were pleased to have partnered with Milbank LLP on the transaction.

More information is available on the Investindustrial website.